Faster Resting Heart Rates Go With Higher Death Risk

Yes, at the population level. A meta-analysis of 46 cohort studies covering 1,246,203 people found a relative risk of 1.09 for death from any cause per 10 beats per minute. In the same 46 cohort studies, people above 80 beats per minute had a relative risk of 1.45 against the lowest category. The link survived adjustment for fitness in a Copenhagen cohort. It cannot forecast one person's lifespan, and no trial shows that lowering the number extends life.

Does a higher resting heart rate mean a higher risk of dying?

In large groups, yes. A meta-analysis of 46 prospective studies pooled 1,246,203 people and 78,349 deaths. Each 10 beats per minute increase carried a relative risk of 1.09 for all-cause death. For cardiovascular death it was 1.08.

A second meta-analysis pooled 87 studies. It reported a relative risk of 1.17 per 10 beats per minute for all-cause mortality. It also found higher risk for coronary heart disease, heart failure and stroke.

The authors of the 46-study analysis detected substantial heterogeneity and publication bias. These are relative risks across whole populations. They describe how groups differ. They do not say what a given reading means for one person.

In 502,534 UK Biobank participants followed for 7 to 12 years, every 10 beats per minute of resting heart rate went with a 22 percent higher risk of death from any cause in men and 19 percent in women, and the associations were stronger at younger ages (PloS One, 2020).

Is there a number that counts as too high?

The pooled data show a gradient, not a cliff. Against the lowest category studied, people at 60 to 80 beats per minute had a relative risk of 1.12 for all-cause death. Above 80 it was 1.45.

So risk appears above the range most charts call normal. A 1997 cohort of 1,827 men and 2,929 women aged 40 to 80 saw the same pattern over 12 years. The authors adjusted for cholesterol, blood pressure, body mass index, smoking and diabetes. Every 20 beats per minute then raised the all-cause hazard ratio to 1.7 in men and 1.4 in women.

A cardiology review notes risk rises continuously above 60 beats per minute. The same review says an optimal rate is hard to define for an individual. This article looks separately at what counts as an elevated resting heart rate.

In 108,257 Chinese adults, a high resting heart rate and a high predicted cardiovascular risk each raised mortality independently, and people with both carried the highest risk, a hazard ratio of 7.16 for cardiovascular death (Heart Rhythm, 2026).

Is resting heart rate just a measure of fitness?

Fitness explains part of it. It does not explain all of it.

The Copenhagen Male Study followed 2,798 healthy men for 16 years, with 1,082 deaths. Resting heart rate was inversely related to fitness. Even so, mortality rose in a graded way after adjusting for fitness, leisure-time activity and other risk factors. Men above 90 beats per minute had a hazard ratio of 3.06 against men at 50 or below.

A Cooper Clinic cohort of 53,322 people found that fitness and heart rate both mattered. Unfit people with low heart rates had about the same risk as fit people with high heart rates. Unfit people with high heart rates had the greatest risk.

Heart rate also carries information that HRV does not. Across 992,611 resting ECGs from a Brazilian telehealth network, people in the highest quarter of heart rate had an 88 percent higher risk of death over six years than the lowest quarter after adjusting for risk factors and for HRV, and low HRV carried its own added risk (The American Journal of Cardiology, 2025).

Does the link hold for every outcome?

No. It varies by outcome and by how heart rate is measured.

The 87-study analysis found a different shape for atrial fibrillation. The relative risk per 10 beats per minute was 0.97 (0.92 to 1.02), and the dose-response was J-shaped rather than rising. It found higher risk for total cancer at 1.14. The 1997 cohort reported no significant link with cancer death. Studies disagree on that point.

The Copenhagen Holter study followed 653 adults aged 55 to 75 with no apparent heart disease. Resting, 24-hour and night-time heart rate all predicted all-cause mortality. For cardiovascular events, the resting and 24-hour links disappeared after full adjustment. Night-time heart rate stayed, with a hazard ratio of 1.17.

In 1,390 German adults followed for 22 years, resting heart rate from a five-minute ECG predicted cardiovascular and coronary death, while RMSSD, the HRV measure most wearables report, showed an association only in people with type 2 diabetes (Scientific Reports, 2026).

Does a wearable reading carry the same information?

The cohort studies above describe clinic readings, resting ECGs and ambulatory monitors. None describes a consumer wrist reading. The link to a watch number is an assumption, not a finding.

A wrist tracker's number also moves. A study of 92,457 adults wearing trackers over about two years found mean daily resting heart rate of 65 beats per minute, with a range of 40 to 109. It varied with age, sex, sleep duration, body mass index and time of year. For 20% of people, at least one week saw resting heart rate swing by 10 beats per minute or more.

That study measured variability, not mortality. It shows why the mortality work relies on repeated measures and long follow-up. How devices produce the number is covered in how wearables measure resting heart rate.

Does lowering resting heart rate lower the risk?

This is the part the evidence does not settle. A 2023 review states that resting heart rate predicts adverse outcomes in otherwise healthy people. It also states that why it does so remains obscure.

The same review says evidence that interventions lowering heart rate improve outcomes in the normal population remains undefined. Heart rate reduction has helped in specific conditions such as heart failure. That does not transfer to healthy adults.

What people try to change the number is covered in what the evidence says about lowering resting heart rate. Whether doing so changes long-term outcomes without existing heart disease is unproven.

Common questions